Preclinical evaluation of an antibody-based companion diagnostic for CD44v6 expressing cancer. Oroujeni M, Selvaraju RK, Persson H, Dahllund L, et al. Nucl Med Commun 2026;47:401-410.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Oroujeni M, Selvaraju RK, Persson H, Dahllund L, et al. Preclinical evaluation of an antibody-based companion diagnostic for CD44v6 expressing cancer. Nucl Med Commun 2026;47:401-410.
PMID: 41496609